

NCT02882113 Raw comparison:

Summary:
CHIA has 14 criteria while your personal folder has 16 criteria
Total found criteria: 14/14
Total not Found: 0/14
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ 19 years old and above                             │ 19 years old and above                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who previously have received a liver      │ Patients who previously have received a liver      │
│ transplant over the last six months and within     │ transplant over the last six months and within     │
│ last three years                                   │ last three years                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are on Tacrolimus immunosuppressive   │ Patients who are on Tacrolimus immunosuppressive   │
│ therapy twice a day for at least two weeks         │ therapy twice a day for at least two weeks         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who have normal liver function and renal  │ Patients who have normal liver function and renal  │
│ function                                           │ function                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who have been monitored without           │ Patients who have been monitored without           │
│ complication such as acute rejection               │ complication such as acute rejection               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients willing to sign his/her consent           │ Patients willing to sign his/her consent           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who have Tacrolimus trough level resulted │ Patients who have Tacrolimus trough level resulted │
│ as 2 ng/mg at the baseline                         │ as 2 ng/mg at the baseline                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are on steroid therapy due to         │ Patients who are on steroid therapy due to         │
│ positive result of acute rejection test before the │ positive result of acute rejection test before the │
│ baseline                                           │ baseline                                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who have received a transplant besides    │ Patients who have received a transplant besides    │
│ liver                                              │ liver                                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are allergic to IP or macrolide       │ Patients who are allergic to IP or macrolide       │
│ compounds                                          │ compounds                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are on cyclosporine bosentan or       │ Patients who are on cyclosporine bosentan or       │
│ potassium sparing diuretic                         │ potassium sparing diuretic                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with genetic diseases such as galactose   │ Patients with genetic diseases such as galactose   │
│ intolerance Lapp lactase deficiency or glucose-    │ intolerance Lapp lactase deficiency or glucose-    │
│ galactose malabsorption                            │ galactose malabsorption                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant or lactating women                        │ Pregnant or lactating women                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients not willing to adhere to study            │ Patients not willing to adhere to study            │
│ procedures/treatments                              │ procedures/treatments                              │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒══════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                          │
╞══════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Must have minimum age of 19 Years                                                                │
├──────────────────────────────────────────────────────────────────────────────────────────────────┤
│ During Tacrolimus immunosuppressive therapy twice a day for at least two weeks patients who have │
│ following conditions                                                                             │
╘══════════════════════════════════════════════════════════════════════════════════════════════════╛